10
Opinion
By centralising and digitising labelling, pharmaceutical companies can create an efficient, streamlined process for producing accurate, compliant labels.
HOW A CENTRALISED LABELLING SOLUTION CAN IMPROVE PHARMA PROCESSES
T
he pharmaceutical industry arguably faces more challenges than most other industries. Regulatory compliance is part and parcel of working in the sector, but, in a business where bringing a drug to market carries such a large investment, cost pressures, particularly when a drug comes off patent, are perhaps higher than other industries.
Ken Moir Marketing Director at NiceLabel
Therefore, finding the balance between complying to regulation, driving efficiencies in the manufacturing process and maintaining quality can mean the difference between being competitive or not. A critical part of maintaining compliance and safety standards for any drug manufacturer is the labelling process. Not only does the label act us a unique identifier to prove authenticity to healthcare professionals and consumers, it also ensures that active ingredients and concentrations are clearly understood. And there can’t be any margin for error as the consequences of inaccurate doses or ingredients are too high.